The Hawaii Department of Health will hold its first public hearing to consider petitions that propose the use of medical cannabis for additional debilitating medical conditions. The hearing will focus on Amyotrophic Lateral Sclerosis (ALS) and General Anxiety Disorder (GAD). The public hearing will be held on Wednesday, September 20, 2017 from 10 am to 11 am at the Kalanimoku Building, 1151 Punchbowl Street, Video Conference Center, Room B10 in the basement.
If you would like to submit testimony but are not able to attend the hearing, you may submit written testimony to the Hawaii Department of Health by mail at 4348 Waialae Avenue, #648, Honolulu, Hawaii 96816 or by email at firstname.lastname@example.org. Please be sure to type “Testimony for 2017 Petition Process” in the email subject line. All testimony must be received no later than September 20, 2017, at 4:30 pm.
You can also participate in the hearing via live video broadcast at the following locations: Hawai‘i Island, Hilo State Office Building, 75 Aupuni Street, Video Conference Center in the basement; Kaua‘i, Lihue State Office Building, 3060 Eiwa Street, Video Conference Center in the basement; Maui, Wailuku State Office Building, 54 South High Street, Video Conference Center, Third Floor; Moloka‘i, Department of Health, 65 Makaena Place, Room 107, Video Conference Room.
It is the Alliance’s mission to provide up-to-date and relevant industry information to the patients, dispensary applicants, and related businesses of Hawai‘i’s growing medicinal cannabis industry. If you are not yet an Alliance member, join today to receive the HDA Industry Update every month and to take an active role in the future of Hawai‘i’s medical marijuana industry. Contact us today and we will send you the Winter 2017 edition of the HDA Industry Update absolutely free to say thank you for your interest!